e.g. mhealth
Search Results (1 to 10 of 85 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 24 JMIR Cardio
- 19 Journal of Medical Internet Research
- 9 JMIR Formative Research
- 7 JMIR Research Protocols
- 5 JMIR Medical Informatics
- 4 JMIRx Med
- 3 Interactive Journal of Medical Research
- 3 JMIR Aging
- 3 JMIR mHealth and uHealth
- 3 JMIRx Bio
- 2 JMIR Human Factors
- 2 JMIR Medical Education
- 1 JMIR Diabetes
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
The universal definition of heart failure (HF) describes it as a clinical syndrome characterized by symptoms or signs caused by structural or functional cardiac abnormalities, corroborated by elevated natriuretic peptide levels or objective evidence of pulmonary or systemic congestion [1,2]. HF has long been regarded as a global pandemic, with an estimated 64 million individuals worldwide with this condition, and this number continues to rise [3].
J Med Internet Res 2025;27:e67228
Download Citation: END BibTex RIS
With landmark clinical trials [3-6] demonstrating the efficacy of the latter drugs, there has been a paradigm shift in initiating and sequencing optimal anti–heart failure therapy and a concomitant reevaluation of the evidence base that guides conventional heart failure management. The American Heart Association heart failure guideline supports the rapid titration of guideline-based therapies every 1-2 weeks, with the goal of achieving target doses [7].
JMIR Res Protoc 2025;14:e44027
Download Citation: END BibTex RIS
However, the most common first stage of medical care is the diagnosis of symptoms that may reflect underlying heart disease, with an estimated 39% of adults experiencing symptoms that can reflect possible underlying heart disease such as chest pain [20]. Therefore, the initial onset of symptoms that may indicate cardiovascular problems affects a far greater number of people than those dealing with recovery from or management of heart disease.
JMIR Cardio 2025;9:e66464
Download Citation: END BibTex RIS
Automated Process for Monitoring of Amiodarone Treatment: Development and Evaluation
However, careful follow-up is necessary during treatment due to potentially serious adverse effects and toxic reactions in the thyroid gland, liver, lung, and heart. Approximately 15% of patients will experience adverse effects during the first year of amiodarone use and 50% during long-term treatment, most often thyroid and liver dysfunction [1].
J Med Internet Res 2025;27:e65473
Download Citation: END BibTex RIS
peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Reference 17: Impaired balance and gait characteristics in patients with chronic heart failure Reference 18: Gait analysis in chronic heart failure: the calf as a locus of impaired walking capacity Reference 31: Wearable device validity in measuring steps, energy expenditure, and heart rate across Reference 32: Treadmill vs. floor walking: kinematics, electromyogram, and heart rateheart
JMIR Form Res 2025;9:e58964
Download Citation: END BibTex RIS
The patient was introduced to the learners as a 65-year-old female in-patient on a hospital cardiac telemetry unit with a past medical history of coronary artery disease, congestive heart failure, and peripheral vascular disease. The simulation began when a facilitator in the role of the patient’s nurse requested help from a participant.
JMIR Med Educ 2025;11:e57424
Download Citation: END BibTex RIS
With the aging population, heart failure (HF) is a growing problem worldwide [1]. In the United States, 8 million individuals are projected to be diagnosed with HF, and the cost of its treatment is expected to reach US $70 billion by 2030 [2-4].
J Med Internet Res 2025;27:e54524
Download Citation: END BibTex RIS
CDSS aid in the evaluation of chest pain and include guidelines from several societies such as the American College of Cardiology and the American Heart Association, with subscription-based databases such as Up To Date [14] or online risk assessment tools such as MDCalc. However, the disadvantages of these resources include cost (with many requiring paid subscriptions) and the inability to incorporate institution-specific protocols.
JMIR Cardio 2024;9:e55958
Download Citation: END BibTex RIS
To enhance ACP completion rates among patients with heart failure and foster a truly patient-centered approach, it is crucial to empower patients to initiate ACP conversations with their caregivers and HCPs. ACP web-based decision aids offer a promising solution, preparing patients for these conversations while alleviating the time burden for clinicians.
JMIR Aging 2024;7:e60117
Download Citation: END BibTex RIS
Heart failure (HF) is the primary cause of hospitalization among patients aged 65 years or older in Canada [1]. Patients with HF require regular clinical follow-ups to prevent readmissions and to facilitate medical therapy optimization in accordance with national [2] and international guidelines [3,4].
JMIR Form Res 2024;8:e53444
Download Citation: END BibTex RIS